Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
Masaki NakamuraNaoki HashimotoHiroshi MayaharaHaruka UezonoAya HaradaRyo NishikawaYoshiro MatsuoHiroki KawaguchiHideki NishimuraPublished in: Radiation oncology (London, England) (2018)
SBRT is a safe and effective treatment for patients with lung and liver oligo-recurrence. Additional chemotherapy after SBRT improved local control, and single metastatic lesion was a significant predictive factor of better PFS in this study. Among colorectal cancer patients, additional chemotherapy after SBRT significantly associated better OS.